EASY BIO, Inc.
KKRX:3538105,450.00
KRW
-120.00
(-2.15%)
ISIN
KR7353810005
Return %
Stock
S&P 500
1Y
-10.36
14.39
3Y
78.10
81.42
5Y
0.00
68.62
Capital Structure
KRW
•
in mil. unless spec.Working Capital
KRW
•
in mil. unless spec.Growth Rates
KRW
•
in mil. unless spec.Quarterly Revenue
KRW
•
in mil. unless spec.Quarterly Earnings Per Share
KRW
•
in mil. unless spec.Quarterly Dividends Per Share
KRW
•
in mil. unless spec.Company Description
- CEO
- Il-Hwan Hwang
- Full Time Employees
- 143
- Sector
- Process industries
- Industry
- Agricultural commodities/Milling
- Address
- Seoul SL South Korea 06253
- IPO Date
- Jun 5, 2020
- Website
- easybio.co.kr
- Similar Companies
- Business
- EASY BIO, Inc. (353810.KQ) manufactures and sells specialized piglet feeds and animal feed additives, including probiotics, enzymes, organic acids, essential oils, and nutrient premixes tailored to species, life stages, and environmental factors; the company offers its Pathway Intermediates brand for integrated feed additive solutions and I-feed branded piglet feeds, along with feed ingredients and biotechnology-based products for sustainable livestock nutrition. EASY BIO, Inc. operates in the animal nutrition and biotechnology sector, primarily serving livestock producers with a focus on piglet and animal health solutions; it targets domestic Korean markets and international customers in over 50 countries, including the United States, Colombia, China, Vietnam, Thailand, Philippines, Indonesia, Japan, and Taiwan. The company maintains production facilities, research centers, and subsidiaries such as Pathway Intermediates International (U.K. joint venture acquired in 2018), EASY BIO Thailand, Pathway Intermediates Vietnam, Pathway Intermediates USA, Pathway Chengdu (China), and Easy Bio Philippines. Founded in 2020 through a spinoff from EASY HOLDINGS to focus on high-growth feed additives and piglet feed segments, EASY BIO, Inc. is headquartered at 4th Floor, 310 Gangnam-daero, Gangnam-gu, Seoul, South Korea. In a key strategic expansion, the company acquired 100% of U.S.-based Devenish Nutrition LLC in 2024 via its subsidiary EASY BIO USA, enhancing its North American feed additive and premix operations with access to five U.S. production plants, six research facilities, and established livestock market presence. This acquisition builds on prior global moves, including the 2019 launch of Pathway Intermediates as a unified global brand and ongoing investments in localized production hubs. In early 2025, Pathway Intermediates participated in IPPE 2025, underscoring EASY BIO's commitment to international visibility and innovation in sustainable animal nutrition.